California Public Employees Retirement System
TBPH

California Public Employees Retirement System’s Theravance Biopharma TBPH Stock Holding History

California Public Employees Retirement System’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-93,700
Closed -$1.91M – 2779
2021
Q1 		$1.91M Sell
93,700
-8,509
-8% -$162K ﹤0.01% 2043
2020
Q4 		$1.82M Sell
102,209
-2,000
-2% -$35.9K ﹤0.01% 2057
2020
Q3 		$1.54M Buy
104,209
+1,146
+1% +$21.5K ﹤0.01% 1979
2020
Q2 		$2.16M Buy
103,063
+1,454
+1% +$37.4K ﹤0.01% 1746
2020
Q1 		$2.35M Buy
101,609
+987
+1% +$24.7K ﹤0.01% 1506
2019
Q4 		$2.6M Buy
100,622
+18,656
+23% +$363K ﹤0.01% 1873
2019
Q3 		$1.6M Buy
81,966
+19,251
+31% +$389K ﹤0.01% 2025
2019
Q2 		$1.02M Buy
62,715
+7,515
+14% +$152K ﹤0.01% 2142
2019
Q1 		$1.25M Sell
55,200
-1,500
-3% -$38K ﹤0.01% 2085
2018
Q4 		$1.45M Sell
56,700
-5,500
-9% -$148K ﹤0.01% 1949
2018
Q3 		$2.03M Sell
62,200
-5,100
-8% -$139K ﹤0.01% 1898
2018
Q2 		$1.53M Sell
67,300
-6,100
-8% -$145K ﹤0.01% 2083
2018
Q1 		$1.78M Sell
73,400
-3,600
-5% -$98.9K ﹤0.01% 1962
2017
Q4 		$2.15M Buy
77,000
+1,800
+2% +$53.3K ﹤0.01% 1905
2017
Q3 		$2.58M Sell
75,200
-10,400
-12% -$340K ﹤0.01% 1752
2017
Q2 		$3.41M Buy
85,600
+2,400
+3% +$92.3K 0.01% 1528
2017
Q1 		$3.06M Sell
83,200
-4,600
-5% -$147K 0.01% 1612
2016
Q4 		$2.8M Sell
87,800
-5,900
-6% -$183K ﹤0.01% 1692
2016
Q3 		$3.4M Buy
93,700
+8,800
+10% +$245K 0.01% 1570
2016
Q2 		$1.93M Sell
84,900
-2,700
-3% -$58.3K ﹤0.01% 1935
2016
Q1 		$1.65M Sell
87,600
-5,300
-6% -$86.7K ﹤0.01% 2018
2015
Q4 		$1.52M Hold
92,900
– – ﹤0.01% 2100
2015
Q3 		$1.02M Sell
92,900
-3,169
-3% -$40.4K ﹤0.01% 2349
2015
Q2 		$1.25M Hold
96,069
– – ﹤0.01% 2365
2015
Q1 		$1.73M Hold
96,069
– – ﹤0.01% 2223
2014
Q4 		$1.73M Buy
96,069
+61,100
+175% +$1.06M ﹤0.01% 2223
2014
Q3 		$806K Sell
34,969
-2
-0% -$58 ﹤0.01% 2649
2014
Q2 		$1.11M Buy
+34,971
New +$1.05M ﹤0.01% 2488

Other funds holding TBPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

California Public Employees Retirement System's TBPH Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Theravance Biopharma (TBPH) in Q2 2021, closing a stake of 93,700 shares — an estimated $1.91M sold.

California Public Employees Retirement System first reported a position in TBPH in Q2 2014 and held it in 28 quarters. The position peaked at $3.41M in Q2 2017. 108 funds tracked by Wall St. Rank hold TBPH as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Theravance Biopharma position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 93,700 Theravance Biopharma shares in Q2 2021, an estimated $1.91M.
  • California Public Employees Retirement System first reported a position in Theravance Biopharma in Q2 2014 and held it in 28 quarters.
  • California Public Employees Retirement System's Theravance Biopharma position peaked at $3.41M in Q2 2017.
  • 108 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.